![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1350745
¼¼°èÀÇ ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåGlobal Bioanalytical Testing Services Market |
¼¼°èÀÇ ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå ±Ô¸ð´Â 2022³â 29¾ï ´Þ·¯, 2023³â 32¾ï ´Þ·¯¿¡¼ ¿¹Ãø±â°£ Áß 15.2%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2028³â¿¡´Â 66¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼ºñ½º Á¾·ùº°·Î´Â ¼¼Æ÷ ±â¹Ý ¾î¼¼ÀÌ ºÎ¹®ÀÌ 2022³â 5¾ï 7,250¸¸ ´Þ·¯, 2023³â 6¾ï 5,300¸¸ ´Þ·¯¿¡¼ 15.7%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2028³â¿¡´Â 14¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ »ý¹°ÇÐÀû µ¿µî¼º ¹× »ýüÀÌ¿ë·ü ¿¬±¸ ºÎ¹®Àº 2022³â 5¾ï 2,360¸¸ ´Þ·¯, 2023³â 5¾ï 9,750¸¸ ´Þ·¯¿¡¼ 16.3%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2028³â¿¡´Â 13¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ ¹ÙÀÌ¿À ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå ¹× ±â¼ú °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ºÐ¼®, ±ÔÁ¦ »óȲ, ½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø, °¢Á¾ ºÎ¹®¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, ±â¼ú ¹× ƯÇã µ¿Çâ, ESG Àü°³, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» Á¤¸®Çß½À´Ï´Ù.
The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.
Cell-Based Assays segment of the global bioanalytical testing services market reached $572.5 million in 2022, should reach $653.0 million by 2023 and $1.4 billion by 2028 with a CAGR of 15.7% during the forecast period of 2023-2028.
Bioequivalence & Bioavailability Studies segment of the global bioanalytical testing services market reached $523.6 million in 2022, should reach $597.5 million by 2023 and $1.3 billion by 2028 with a CAGR of 16.3% during the forecast period of 2023-2028.
The report's scope includes an overview of the global market on bioanalytical testing services and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes leading services, applications, end user, and product details for the bioanalytical testing services market. Leading market players' profiles, specific services, financial information, and recent market activities are provided. This report also assesses companies' mergers & acquisitions and funding activities and their impact in the face of the competitive environment. The report details the bioanalytical testing services market based on service type, application, and end user. The market is segmented into pharmacokinetics studies, bioequivalence and bioavailability studies, biomarker testing services, cell-based assays, virology testing, method development, optimization & validation, serology, immunogenicity, and neutralizing antibodies, and others.
The market is categorized as oncology, immunology, neurology, infectious diseases, cardiovascular diseases, and others. The market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and others. The report also consists of the impact of the COVID-19 pandemic on this market. Regional analysis includes North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the World (South America, and the Middle East and Africa).